Detalhe da pesquisa
1.
Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL).
Exp Parasitol
; 257: 108687, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114040
2.
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis.
J Antimicrob Chemother
; 78(7): 1723-1731, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229566
3.
Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria.
Nat Prod Rep
; 38(12): 2214-2235, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913053
4.
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In Vitro.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871082
5.
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis.
Molecules
; 25(17)2020 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887341
6.
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Molecules
; 25(18)2020 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916994
7.
Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262757
8.
Leishmaniasis.
Lancet
; 392(10151): 951-970, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126638
9.
Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis.
Antimicrob Agents Chemother
; 62(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263075
10.
Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082295
11.
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29507073
12.
Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages.
J Antimicrob Chemother
; 73(5): 1314-1323, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506127
13.
Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD.
Parasitology
; 145(2): 237-247, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28982394
14.
Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630200
15.
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis.
Antimicrob Agents Chemother
; 61(8)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607026
16.
Antiprotozoal glutathione derivatives with flagellar membrane binding activity against T. brucei rhodesiense.
Bioorg Med Chem
; 25(4): 1329-1340, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28131508
17.
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
Molecules
; 22(12)2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29194347
18.
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani.
Antimicrob Agents Chemother
; 60(6): 3524-32, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27021313
19.
Drug permeation and barrier damage in Leishmania-infected mouse skin.
J Antimicrob Chemother
; 71(6): 1578-85, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26903275
20.
Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.
Antimicrob Agents Chemother
; 59(9): 5819-23, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055371